$74.5 Million
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$172.6 Million
Arcturus Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$62.2 Million
Aptose Biosciences Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$80.0 Million
NantKwest (acquired by ImmunityBio)
Confidentially Marketed Follow-On Offering
Left Bookrunner
$86.5 Million
OrthoPediatrics Corp.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$55.0 Million
Zynex, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$50.0 Million
Matinas BioPharma Holdings, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$65.9 Million
OrthoPediatrics Corp.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$74.2 Million
Aptose Biosciences Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$55.0 Million
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to Left Bookrunner

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.